The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The use of spirocyclic scaffolds in drug discovery
Open accessAbstract
Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery. In this brief review, we highlight selected examples from the primary medicinal chemistry literature during the last three years to demonstrate the versatility of spiro scaffolds. With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
The Practice of Medicinal Chemistry
(2003) · Elsevier eBooks · doi:10.1016/b978-0-12-744481-9.x5000-4 · Cited by 702
Oxetanes as Versatile Elements in Drug Discovery and Synthesis
Burkhard, J. A., Wuitschik, G., Rogers‐Evans, M., Müller, K., & Carreira, E. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907155 · Cited by 441
Oxetanes in Drug Discovery: Structural and Synthetic Insights
Wuitschik, G., Carreira, E. M., Wagner, B., Fischer, H., Parrilla, I., Schuler, F., Rogers-Evans, M., & Müller, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018788 · Cited by 418
New and unusual scaffolds in medicinal chemistry
Marson, C. M. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15119c · Cited by 413
Two‐ and Three‐dimensional Rings in Drugs
Aldeghi, M., Malhotra, S., Selwood, D. L., & Chan, A. W. E. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12260 · Cited by 372
Direct Stereospecific Synthesis of Unprotected N-H and N-Me Aziridines from Olefins
Jat, J. L., Paudyal, M. P., Gao, H., Xu, Q.-L., Yousufuddin, M., Devarajan, D., Ess, D. H., Kürti, L., & Falck, J. R. (2014) · Science · doi:10.1126/science.1245727 · Cited by 332
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective
Bagal, S. K., Brown, A. D., Cox, P. J., Omoto, K., Owen, R. M., Pryde, D. C., Sidders, B., Skerratt, S. E., Stevens, E. B., Storer, R. I., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3011433 · Cited by 316
Link, J. O., Taylor, J. G., Xu, L., Mitchell, M., Guo, H., Liu, H., Kato, D., Kirschberg, T., Sun, J., Squires, N., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401499g · Cited by 295
Zhao, Y., Yu, S., Sun, W., Liu, L., Lu, J., McEachern, D., Shargary, S., Bernard, D., Li, X., Zhao, T., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005708 · Cited by 290
Route to three-dimensional fragments using diversity-oriented synthesis
Hung, A. W., Ramek, A., Wang, Y., Kaya, T., Wilson, J. A., Clemons, P. A., & Young, D. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015271108 · Cited by 268
Conformational energy penalties of protein-bound ligands
Boström, J., Norrby, P.-O., & Liljefors, T. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008007507641 · Cited by 245
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Sweis, R. F., Pliushchev, M., Brown, P. J., Guo, J., Li, F., Maag, D., Petros, A. M., Soni, N. B., Tse, C., Vedadi, M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400496h · Cited by 193
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
The Lipogenesis Pathway as a Cancer Target
Abramson, H. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005805 · Cited by 165
Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
Goldberg, Y. P., Price, N., Namdari, R., Cohen, C. J., Lamers, M. H., Winters, C., Price, J., Young, C. E., Verschoof, H., Sherrington, R. P., et al. (2011) · Pain · doi:10.1016/j.pain.2011.09.008 · Cited by 149
Yuan, J., Venkatraman, S., Zheng, Y., McKeever, B. M., Dillard, L. W., & Singh, S. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301659n · Cited by 135
Self-citationBetschart, C., Hintermann, S., Behnke, D., Cotesta, S., Fendt, M., Gee, C. E., Jacobson, L. H., Laue, G., Ofner, S., Chaudhari, V. D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4007627 · Cited by 105
Zhang, Z., Chu, X., Liu, J., Ding, Q., Zhang, J., Bartkovitz, D., Jiang, N., Karnachi, P., So, S., Tovar, C., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400359z · Cited by 97
Bertamino, A., Soprano, M., Musella, S., Rusciano, M. R., Sala, M., Vernieri, E., Sarno, V. D., Limatola, A., Carotenuto, A., Cosconati, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400311n · Cited by 89
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Wang, Y., Liu, J., Dransfield, P. J., Zhu, L., Wang, Z., Du, X., Jiao, X., Su, Y., Li, A., Brown, S. P., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300427u · Cited by 87
Zhang, Z., Dales, N. A., & Winther, M. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401516c · Cited by 87
O’Reilly, M. C., Scott, S. A., Brown, K. A., Oguin, T. H., Thomas, P. G., Daniels, J. S., Morrison, R. D., Brown, H. A., & Lindsley, C. W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301782e · Cited by 75
Bhattacharya, S. K., Andrews, K., Beveridge, R., Cameron, K. O., Chen, C., Dunn, M., Fernando, D., Gao, H., Hepworth, D., Jackson, V. M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400473x · Cited by 73
Inhibitors of the p53/hdm2 protein–protein interaction—path to the clinic
Carry, J., & García-Echeverría, C. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.034 · Cited by 73
Qiao, J. X., Wang, T. C., Ruel, R., Thibeault, C., L’Heureux, A., Schumacher, W. A., Spronk, S. A., Hiebert, S., Bouthillier, G., Lloyd, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4013906 · Cited by 73
Huang, H., La, D. S., Cheng, A. C., Whittington, D. A., Patel, V. F., Chen, K., Dineen, T. A., Epstein, O. I., Graceffa, R. F., Hickman, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300598e · Cited by 70
Synthesis and evaluation of spiroisoxazoline oxindoles as anticancer agents
Ribeiro, C. J. A., Amaral, J. D., Rodrigues, C. M. P., Moreira, R., & Santos, M. M. M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.048 · Cited by 67
Váchal, P., Miao, S., Pierce, J. M., Guiadeen, D., Colandrea, V. J., Wyvratt, M. J., Salowe, S. P., Sonatore, L. M., Milligan, J. A., Hajdu, R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201542d · Cited by 67
Weiss, M. M., Williamson, T. L., Babu‐Khan, S., Bartberger, M. D., Brown, J., Chen, K., Cheng, Y., Citron, M., Croghan, M. D., Dineen, T. A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300119p · Cited by 66
Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators
Mazurov, A. A., Speake, J. D., & Yohannes, D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007672 · Cited by 66
Efremov, I. V., Vajdos, F. F., Borzilleri, K. A., Capetta, S. H., Chen, H., Dorff, P. H., Dutra, J. K., Goldstein, S. W., Mansour, M. N., McColl, A. S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201715d · Cited by 65
Optimization of Antitumor Modulators of Pre-mRNA Splicing
Lagisetti, C., Palacios, G. F., Goronga, T., Freeman, B. B., Caufield, W. V., & Webb, T. R. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401370h · Cited by 64
Hunt, K. W., Cook, A. W., Watts, R. J., Clark, C. T., Vigers, G. P. A., Smith, D. J., Metcalf, A. T., Gunawardana, I. W. K., Burkard, M., Cox, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4002154 · Cited by 63
Brodney, M. A., Barreiro, G., Ogilvie, K., Hajós‐Korcsok, É., Murray, J. C., Vajdos, F. F., Ambroise, C., Christoffersen, C. L., Fisher, K. E., Lanyon, L. F., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3009426 · Cited by 60
Varasi, M., Thaler, F., Abate, A., Bigogno, C., Boggio, R., Carenzi, G. E. A., Cataudella, T., Zuffo, R. D., Fulco, M. C., Rozio, M. G., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200146u · Cited by 55
Kamata, M., Yamashita, T., Kina, A., Funata, M., Mizukami, A., Sasaki, M., Tani, A., Funami, M., Amano, N., & FUKATSU, K. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.047 · Cited by 52
Novel and selective spiroindoline-based inhibitors of sky kinase
Powell, N. A., Kohrt, J. T., Filipski, K. J., Kaufman, M. D., Sheehan, D. J., Edmunds, J. E., Delaney, A. M., Wang, Y., Bourbonais, F., Lee, D., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.036 · Cited by 50
Griffith, D. A., Dow, R. L., Huard, K., Edmonds, D. J., Bagley, S. W., Polívková, J., Zeng, D., García-Irizarry, C. N., Southers, J. A., Esler, W. P., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401033t · Cited by 49
Dineen, T. A., Weiss, M. M., Williamson, T. L., Acton, P., Babu‐Khan, S., Bartberger, M. D., Brown, J., Chen, K., Cheng, Y., Citron, M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300118s · Cited by 45
Watterson, S. H., Xiao, Z., Dodd, D. S., Tortolani, D. R., Vaccaro, W. D., Potin, D., Launay, M., Stetsko, D. K., Skala, S., Davis, P. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100348u · Cited by 43
Kazmierski, W. M., Maynard, A. T., Duan, M., Baskaran, S., Botyanszki, J., Crosby, R. M., Dickerson, S. H., Tallant, M. D., Grimes, R. M., Hamatake, R. K., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4013104 · Cited by 42
Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors
Kamata, M., Yamashita, T., Kina, A., Tawada, M., Endo, S., Mizukami, A., Sasaki, M., Tani, A., Nakano, Y., Watanabe, Y., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.062 · Cited by 42
Serendipitous Discovery of a Potent Influenza Virus A Neuraminidase Inhibitor
Mohan, S., Kerry, P. S., Bance, N., Niikura, M., & Pinto, B. M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201308142 · Cited by 42
Thomas, A. A., Hunt, K. W., Volgraf, M., Watts, R. J., Liu, X., Vigers, G. P. A., Smith, D. J., Sammond, D. M., Tang, T. P., Rhodes, S. P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401635n · Cited by 42
Tanaka, H., Yoshida, S., Minoura, H., Negoro, K., Shimaya, A., Shimokawa, T., & Shibasaki, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.11.010 · Cited by 41
Schläger, T., Schepmann, D., Lehmkuhl, K., Holenz, J., Vela, J. M., Buschmann, H., & Wünsch, B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200585k · Cited by 41
Poslusney, M. S., Melancon, B. J., Gentry, P. R., Sheffler, D. J., Bridges, T. M., Utley, T. J., Daniels, J. S., Niswender, C. M., Conn, P. J., Lindsley, C. W., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.017 · Cited by 32
Stachel, S. J., Steele, T. G., Petrocchi, A., Haugabook, S. J., McGaughey, G. B., Holloway, M. K., Allison, T. J., Munshi, S. K., Zuck, P. D., Colussi, D. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.024 · Cited by 31
Donnell, A. F., Michoud, C., Rupert, K. C., Han, X., Aguilar, D., Frank, K. B., Fretland, A. J., Gao, L., Goggin, B. S., Hogg, J. H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400731m · Cited by 31
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase
Keith, J. M., Jones, W. M., Pierce, J. M., Seierstad, M. J., Palmer, J. A., Webb, M., Karbarz, M. J., Scott, B. P., Wilson, S. J., Luo, L., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.113 · Cited by 30
Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design
Tice, C. M., Zhao, W. L., Xu, Z., Cacatian, S. T., Simpson, R. D., Ye, Y.-J., Singh, S. B., McKeever, B. M., Lindblom, P., Guo, J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.082 · Cited by 29
Self-citationAzetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors
Bondada, L., Rondla, R., Pradère, U., Liu, P., Li, C., Bobeck, D. R., McBrayer, T. R., Tharnish, P., Courcambeck, J., Halfon, P., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.068 · Cited by 28
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor
McClure, K. F., Jackson, M., Cameron, K. O., Kung, D. W., Perry, D. A., Orr, S. T. M., Zhang, Y., Kohrt, J. T., Tu, M., Gao, H., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.044 · Cited by 28
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor
Kung, D. W., Coffey, S. B., Jones, R. M., Cabral, S., Jiao, W., Fichtner, M. W., Carpino, P. A., Rose, C. R., Hank, R. F., Lopaze, M. G., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.024 · Cited by 27
Seto, S., Yumoto, K., Okada, K., Asahina, Y., Iwane, A., Iwago, M., Terasawa, R., Shreder, K. R., Murakami, K., & Kohno, Y. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.046 · Cited by 26
Li, Y., Wang, X., Zhang, J., Deuther‐Conrad, W., Xie, F., Zhang, X., Liu, J., Qiao, J., Cui, M., Steinbach, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301734g · Cited by 26
Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists
Hanessian, S., Jennequin, T., Boyer, N. C., Babonneau, V., Soma, U., la Cour, C. M., Millan, M. J., & Nanteuil, G. D. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400528y · Cited by 21
Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors
Kaptein, A., Oubrie, A., de Zwart, E., Hoogenboom, N., de Wit, J., van de Kar, B., Hoek, M. E.-V., Vogel, G. M. T., de Kimpe, V., Schultz‐Fademrecht, C., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.016 · Cited by 20
Oberdorf, C., Schepmann, D., Vela, J. M., Buschmann, H., Holenz, J., & Wünsch, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300302p · Cited by 19
Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1)
Deng, Y., Yang, Z., Shipps, G. W., Lo, S., West, R., Hwa, J. J., Zheng, S., Farley, C., Lachowicz, J. E., van Heek, M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.075 · Cited by 19
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists
Fujimoto, T., Tomata, Y., Kunitomo, J., Hirozane, M., & Marui, S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.094 · Cited by 17
Allen, C. E., Chow, C. L., Caldwell, J., Westwood, I. M., van Montfort, R. L. M., & Collins, I. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.07.021 · Cited by 16
Zhou, H., Topiol, S. W., Grenon, M., Jimenez, H. N., Uberti, M. A., Smith, D. G., Brodbeck, R. M., Chandrasena, G., Pedersen, H., Madsen, J. C., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.12.078 · Cited by 12
Liang, G., Choi-Sledeski, Y. M., Poli, G. B., Chen, X., Minnich, A., Wang, Q., Tsay, J. T., Sides, K., & Vaz, R. J. (2011) · MedChemComm · doi:10.1039/c1md00104c · Cited by 9
Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor
Fichtner, M. W., Lee, E.-S., Tomlinson, E., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.098 · Cited by 8
Hossain, N., Mensonides-Harsema, M. M., Cooper, M., Eriksson, T., Ivanova, S., & Bergström, L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.062 · Cited by 8
Cited by
Visible Light-Driven Radical-Mediated C–C Bond Cleavage/Functionalization in Organic Synthesis
Yu, X.-Y., Chen, J.-R., & Xiao, W.-J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00030 · Cited by 1,143
Catalytic Enantioselective Desymmetrization Reactions to All-Carbon Quaternary Stereocenters
Zeng, X.-P., Cao, Z.-Y., Wang, Y.-H., Zhou, F., & Zhou, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00094 · Cited by 807
Spirocyclic Scaffolds in Medicinal Chemistry
Hiesinger, K., Dar’in, D., Proschak, E., & Krasavin, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01473 · Cited by 618
Khandelwal, S., Tailor, Y. K., & Kumar, M. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.12.015 · Cited by 572
Therapeutic Potential of Spirooxindoles as Antiviral Agents
Ye, N., Chen, H., Wold, E. A., Shi, P.-Y., & Zhou, J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00041 · Cited by 493
Metadata
- Authors
- Zheng, Y., Tice, C. M., & Singh, S. B.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 24
- Issue
- 16
- Pages
- 3673-3682
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W2029526231
- Cited by
- 1,036
- References
- 72
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.